BTX-A51
UNII L46P54NB4V
Substance Identification & Data
This profile provides standardized clinical and technical data for Btx-a51, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L46P54NB4V.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
L46P54NB4V
N/A
N/A
Detailed Substance Profile
Preferred Name
BTX-A51
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C18H25ClN6 International Chemical Identifier digital signature for unique molecular identification.
SMILES String
RVZJFCNYSSUDCU-JOCQHMNTSA-N Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C1[C@@H](N)CC[C@H](Nc2ncc(Cl)c(-c3cnn(C)c3CC4CC4)n2)C1
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Btx-a51. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
Systematic Nomenclature
TRANS-N1-(5-CHLORO-4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)-2-PYRIMIDINYL)-1,4-CYCLOHEXANEDIAMINE
Technical Codes
BTX-A51